×
About 8,012 results

ALLMedicine™ Angioedema Center

Research & Reviews  3,383 results

Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Ma...
https://doi.org/10.1159/000512933
International Archives of Allergy and Immunology; Sobotkova M, Zachova R et. al.

Jan 20th, 2021 - Acquired angioedema with C1 inhibitor deficiency (AAE-C1-INH) is rare but a potentially life-threatening disease. There are no official prevalence data, nor approved therapies for this condition. In this study, we aimed to collect and analyze clin...

Solifenacin-induced acute urticaria and angioedema: a rare adverse effect.
https://doi.org/10.1136/postgradmedj-2020-138375
Postgraduate Medical Journal; Younas U, Shafiq O et. al.

Jan 16th, 2021 - Antimuscarinics are first-line medication for management of overactive bladder with solifenacin being commonly prescribed. Angioedema is the swelling of mucosa and submucosal tissue. There are no published case reports of drug-induced angioedema i...

Quality of Life in Patients with Hereditary Angioedema in Canada.
https://doi.org/10.1016/j.anai.2021.01.002
Annals of Allergy, Asthma & Immunology : Official Publica... Lee EY, Hsieh J et. al.

Jan 15th, 2021 - Hereditary angioedema (HAE) is associated with decreased quality of life (QoL), which has typically been measured using a generic non-disease specific questionnaire. We aimed to assess the QoL in patients with HAE Type I and II in Canada, using a ...

Pathophysiology of Hereditary Angioedema (HAE) Beyond the SERPING1 Gene.
https://doi.org/10.1007/s12016-021-08835-8 10.1016/j.jaad.2004.09.032 10.1056/NEJMra1808012 10.1016/j.gendis.2019.07.002 10.1016/j.jaci.2018.01.015 10.1007/s12016-016-8543-x 10.3389/fgene.2019.00900 10.1016/j.jaci.2017.05.020 10.1111/all.13270 10.1016/j.bbrc.2006.03.092 10.1111/all.13869 10.1111/all.14454 10.1172/JCI103109 10.1016/S0021-9258(17)38776-8 10.1186/1710-1492-6-16 10.1111/hae.12519 10.1111/all.12648 10.1016/j.amjmed.2007.08.021 10.1016/j.anai.2016.09.001 10.1016/j.iac.2017.04.004 10.1016/S0140-6736(00)02483-1 10.1067/mai.2000.108106 10.1002/pro.5560020504 10.3389/fimmu.2019.02046 10.1086/509899 10.1016/j.clim.2011.07.002 10.1097/MBC.0b013e32832811f8 10.1261/rna.068916.118 10.1111/jdv.14056 10.1186/1710-1492-6-15 10.1016/j.amjmed.2005.09.064 10.1097/00005792-199207000-00003 10.1111/cei.12820 10.1111/j.1398-9995.2010.02368.x 10.1111/all.13076 10.1016/j.clim.2015.02.013 10.1111/j.1365-2249.2012.04574.x 10.1111/cea.12055 10.1021/bi100687f 10.1016/j.bbrc.2017.12.060 10.1186/s13601-019-0247-x 10.1111/all.13543 10.1111/all.13550 10.1111/all.13324 10.1186/s13223-019-0346-1 10.1111/cea.13349 10.1111/all.13667 10.1074/jbc.M704798200 10.1016/j.vph.2011.04.001 10.1093/bja/aeh163 10.1016/j.coph.2019.03.008 10.2174/1874192401004010302 10.3389/fmed.2017.00206 10.1016/j.molimm.2020.01.003 10.1016/j.jaci.2016.12.982 10.1111/all.12520 10.1111/cea.13219
Clinical Reviews in Allergy & Immunology References; Sharma J, Jindal AK et. al.

Jan 14th, 2021 - Hereditary Angioedema (HAE) is an autosomal dominant disorder characterized clinically by recurrent episodes of swelling involving subcutaneous tissues, gastrointestinal tract, and oro-pharyngeal area. Gene mutations are the most common genetic ca...

see more →

Guidelines  19 results

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2...
https://doi.org/10.1111/all.13384
Allergy Maurer M, Magerl M et. al.

Jan 10th, 2018 - Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and appropriate therapy are essential. This update and revision of the global guideline for HAE provides up-to-date consensus recommendations for the management of HAE. I...

BSACI guideline for the management of chronic urticaria and angioedema.
https://doi.org/10.1111/cea.12494
Clinical and Experimental Allergy : Journal of the Britis... Powell RJ, Leech SC et. al.

Feb 25th, 2015 - This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well ...

The diagnosis and management of acute and chronic urticaria: 2014 update
https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Urticaria-2014.pdf
Bernstein, J.

Apr 30th, 2014 - Theworkgroup was formed by the JTFPP to develop a practiceparameter to address the diagnosis and treatment of urticaria withor without angioedema. The chair, Jonathan Bernstein, MD,invited workgroup members to participate in the parameterdevelopme.

A consensus parameter for the evaluation and management of angioedema in the emergency ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100605
Academic Emergency Medicine : Official Journal of the Soc... Moellman JJ, Bernstein JA et. al.

Apr 15th, 2014 - Despite its relatively common occurrence and life-threatening potential, the management of angioedema in the emergency department (ED) is lacking in terms of a structured approach. It is paramount to distinguish the different etiologies of angioed...

A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, an...
https://doi.org/10.1016/j.jaci.2013.03.034
The Journal of Allergy and Clinical Immunology; Zuraw BL, Bernstein JA et. al.

Jun 3rd, 2013 - These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP), representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council ...

see more →

Drugs  413 results see all →

Clinicaltrials.gov  3,953 results

Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Ma...
https://doi.org/10.1159/000512933
International Archives of Allergy and Immunology; Sobotkova M, Zachova R et. al.

Jan 20th, 2021 - Acquired angioedema with C1 inhibitor deficiency (AAE-C1-INH) is rare but a potentially life-threatening disease. There are no official prevalence data, nor approved therapies for this condition. In this study, we aimed to collect and analyze clin...

Solifenacin-induced acute urticaria and angioedema: a rare adverse effect.
https://doi.org/10.1136/postgradmedj-2020-138375
Postgraduate Medical Journal; Younas U, Shafiq O et. al.

Jan 16th, 2021 - Antimuscarinics are first-line medication for management of overactive bladder with solifenacin being commonly prescribed. Angioedema is the swelling of mucosa and submucosal tissue. There are no published case reports of drug-induced angioedema i...

Quality of Life in Patients with Hereditary Angioedema in Canada.
https://doi.org/10.1016/j.anai.2021.01.002
Annals of Allergy, Asthma & Immunology : Official Publica... Lee EY, Hsieh J et. al.

Jan 15th, 2021 - Hereditary angioedema (HAE) is associated with decreased quality of life (QoL), which has typically been measured using a generic non-disease specific questionnaire. We aimed to assess the QoL in patients with HAE Type I and II in Canada, using a ...

Pathophysiology of Hereditary Angioedema (HAE) Beyond the SERPING1 Gene.
https://doi.org/10.1007/s12016-021-08835-8 10.1016/j.jaad.2004.09.032 10.1056/NEJMra1808012 10.1016/j.gendis.2019.07.002 10.1016/j.jaci.2018.01.015 10.1007/s12016-016-8543-x 10.3389/fgene.2019.00900 10.1016/j.jaci.2017.05.020 10.1111/all.13270 10.1016/j.bbrc.2006.03.092 10.1111/all.13869 10.1111/all.14454 10.1172/JCI103109 10.1016/S0021-9258(17)38776-8 10.1186/1710-1492-6-16 10.1111/hae.12519 10.1111/all.12648 10.1016/j.amjmed.2007.08.021 10.1016/j.anai.2016.09.001 10.1016/j.iac.2017.04.004 10.1016/S0140-6736(00)02483-1 10.1067/mai.2000.108106 10.1002/pro.5560020504 10.3389/fimmu.2019.02046 10.1086/509899 10.1016/j.clim.2011.07.002 10.1097/MBC.0b013e32832811f8 10.1261/rna.068916.118 10.1111/jdv.14056 10.1186/1710-1492-6-15 10.1016/j.amjmed.2005.09.064 10.1097/00005792-199207000-00003 10.1111/cei.12820 10.1111/j.1398-9995.2010.02368.x 10.1111/all.13076 10.1016/j.clim.2015.02.013 10.1111/j.1365-2249.2012.04574.x 10.1111/cea.12055 10.1021/bi100687f 10.1016/j.bbrc.2017.12.060 10.1186/s13601-019-0247-x 10.1111/all.13543 10.1111/all.13550 10.1111/all.13324 10.1186/s13223-019-0346-1 10.1111/cea.13349 10.1111/all.13667 10.1074/jbc.M704798200 10.1016/j.vph.2011.04.001 10.1093/bja/aeh163 10.1016/j.coph.2019.03.008 10.2174/1874192401004010302 10.3389/fmed.2017.00206 10.1016/j.molimm.2020.01.003 10.1016/j.jaci.2016.12.982 10.1111/all.12520 10.1111/cea.13219
Clinical Reviews in Allergy & Immunology References; Sharma J, Jindal AK et. al.

Jan 14th, 2021 - Hereditary Angioedema (HAE) is an autosomal dominant disorder characterized clinically by recurrent episodes of swelling involving subcutaneous tissues, gastrointestinal tract, and oro-pharyngeal area. Gene mutations are the most common genetic ca...

see more →

News  235 results

Fast Five Quiz: Food Allergies
https://reference.staging.medscape.com/viewarticle/936716_3

Sep 7th, 2020 - Although anaphylaxis can occur without skin symptoms, cutaneous reactions are the most common clinical manifestations of an allergic reaction to a food or food additive. Peanuts remain the most common cause of severe food allergy symptoms and anap...

Recurrent Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema Refractory to Fresh Frozen Plasma
https://www.mdedge.com/fedprac/article/213630/hospital-medicine/recurrent-angiotensin-converting-enzyme-inhibitor-induced/page/0/1?channel=327

Dec 5th, 2019 - Discussion The standard therapy for ACEI-inducedangioedema continues to be airway management and discontinuation of medication. However, life-threatening progression of symptoms have led to the use of off-label therapies, including FFP and bradyki.

FDA Drug Approvals: Pediatrics — Year in Review 2018
https://reference.medscape.com/viewarticle/907375

Jan 14th, 2019 - New Antimicrobials New tetracyclines and antimicrobials for influenza, malaria, onchocerciasis, smallpox, and more New Drugs in Oncology and Hematology Include a wide range of targeted therapies and first-in-class agents New Drugs in Immunology Ne...

HAE Attacks Cut With Lanadelumab
https://www.medpagetoday.com/rheumatology/generalrheumatology/76622

Nov 30th, 2018 - Action Points Patients with type I or type II hereditary angioedema (HAE) suffer from regular, unpredictable and life-disrupting attacks, and patients are in need of better drugs to control this lifelong disabling condition. Patients whose HAE is ...

Trial Data Back Lanadelumab for HAE Prevention
https://www.medpagetoday.com/rheumatology/generalrheumatology/76542

Nov 27th, 2018 - Prophylactic treatment with lanadelumab (Takhzyro) prevented hereditary angioedema attacks and led to a clinically-meaningful impact on quality of life, according to the pivotal HELP trial that led to recent FDA approval. The monoclonal antibody c...

see more →

Patient Education  9 results see all →